Change of Name

Recorded: 2024-08-09 Pages: 18

Assignor

ARROWHEAD RESEARCH CORPORATION

Executed: 2016-04-05

Assignee

ARROWHEAD PHARMACEUTICALS, INC.

225 SOUTH LAKE AVE., SUITE 1050, PASADENA, CALIFORNIA, 91101

Covered Properties (5)

Rnai Inhibition of Alpha-Enac Expression

Patent: 7,718,632 →

Application: 12/140,112 →

Publication: US 2009/0156529

RNAi Inhibition of Alpha-ENaC Expression

Patent: 9,074,212 →

Application: 12/683,146 →

Publication: US 2010/0190714

Rnai Inhibition of Alpha-Enac Expression

Patent: 7,943,592 →

Application: 12/771,470 →

Publication: US 2010/0210513

Rnai Inhibition of Alpha-Enac Expression

Patent: 7,939,508 →

Application: 12/771,518 →

Publication: US 2010/0216971

Rnai Inhibition of Alpha-Enac Expression

Patent: 8,119,612 →

Application: 12/771,566 →

Publication: US 2010/0216972

Related Assignments (2)

Other recorded transfers of the patents in this record — the chain of ownership.